We serve Chemical Name:4-Bromo-2,6-dimethylbenzaldehyde CAS:5769-33-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:4-Bromo-2,6-dimethylbenzaldehyde
CAS.NO:5769-33-5
Synonyms:Benzaldehyde,4-bromo-2,6-dimethyl;2,6-dimethyl-4-bromobenzaldehyde;4-Bromo-2,6-dimethylbenzaldehyde;2,6-Dimethyl-4-brom-benzaldehyd;Benzaldehyde, 4-bromo-2,6-dimethyl-
Molecular Formula:C9H9BrO
Molecular Weight:213.071
HS Code:2913000090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:284.1±28.0 °C at 760 mmHg
Density:1.4±0.1 g/cm3
Index of Refraction:1.587
PSA:17.07000
Exact Mass:211.983673
LogP:3.49
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like Benzaldehyde,4-bromo-2,6-dimethyl chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Benzaldehyde, 4-bromo-2,6-dimethyl- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-Bromo-2,6-dimethylbenzaldehyde Use and application,Benzaldehyde,4-bromo-2,6-dimethyl technical grade,usp/ep/jp grade.
Related News: In addition, the manufacturing process of MSP-1014 precludes the phosphorylation step, one of the most challenging chemical synthesis steps in psilocybin manufacturing. (3-[(6-Nitro-1H-indole-2-carbonyl)-amino]-propyl)-carbamic acid tert-butyl ester manufacturers India and China are two of the leading players in that game, and US legislators for months have pushed for an aggressive “onshoring” of drug production to counteract the nation’s reliance on foreign producers. Israel, a key ally to the US, could be a logical partner in that effort, but the Trump administration also took out big bets on US firms to set up shop stateside. 5-(6-chloro-hexyl)-pyridine-2-carboxylic acid suppliers Patients having Zynteglo treatment for beta thalassaemia also need conditioning treatment to clear out their bone marrow cells before receiving Zynteglo. Healthcare professionals should therefore explicitly inform patients receiving Zynteglo of the increased risk of blood cancers from medicines used in conditioning treatments. L-Proline,L-cysteinyl-L-tyrosyl-L-threonyl-L-histidyl-L-seryl-L-phenylalanyl-L-seryl- vendor & factory.
